All compounds
Fat lossGH Fragment
AOD-9604
Lipolytic Fragment | Targeted Fat Research
Typical Dose
250–500 mcg
Route
Injectable
Variants
5mg
Overview
What is AOD-9604?
AOD-9604 is a modified C-terminal fragment of human growth hormone (residues 176–191) studied for fat metabolism without the systemic GH-like effects on IGF-1 or glucose.
Mechanism of Action
Binds adipocyte beta-3 receptors, stimulating lipolysis and inhibiting lipogenesis. Does not bind the GH receptor — no impact on growth or insulin sensitivity.
Key Benefits
- Targeted adipose tissue breakdown
- No effect on blood glucose
- Preserves lean muscle mass
- Convenient daily dosing
Research Indications
Stubborn fat reductionEffective
Metabolic rate supportModerate
Cartilage / joint researchModerate
Research Protocols
Disclaimer
These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Conservative | 250 mcg | 1x daily | Subcutaneous (AM, fasted) |
| Standard starting dose | 300 mcg | 1x daily | Subcutaneous |
| Typical maintenance | 400 mcg | 1x daily 5/7 days | Subcutaneous |
| Maximum | 500 mcg | 1x daily | Subcutaneous |
Peptide Interactions
Tesamorelin
Enhanced visceral fat reduction
CJC-1295 / Ipamorelin
Semaglutide / Tirzepatide
Insulin
Side Effects & Safety
Common Side Effects
- Mild injection-site irritation
- Occasional headache
- Transient fatigue
Safety Guidelines
- For laboratory research use only — not for human consumption
- Store reconstituted vials at 2–8°C, use within 30 days
- Rotate injection sites to avoid local irritation
- Discontinue and consult a clinician if adverse reactions occur
Quality Indicators
- ≥95% purity verified by HPLC
- Third-party tested for sterility
- Lyophilized in sealed multi-dose vial
- Bacteriostatic water reconstitution
- Refrigerated cold-chain shipping
What to Expect
- 1Week 1–2Subtle appetite normalization
- 2Week 3–4Visible reduction in soft tissue fat
- 3Week 5–8Improved body composition
- 4Week 9–12Stabilized lipolytic effect
Need a different compound?
Browse all peptides